RBP7 is epigenetically silenced by DNA methylation in the promoter region in a high frequency of nasopharyngeal carcinomas as well as in some cancer cell lines (colon, prostatic and ovarian cancer) (Kwong et al, 2005). Here, RBP7 is linked to cancer.